From these data we suggested that in COVID-19 there is an increase in levels in pro-inflammatory cytokines, including LIGHT, which induce an increase in AT1-AA (AT1 receptor agonists), promoting the pro-inflammatory RAS activity. This evidence concerns the gene AGTR1 and COVID-19.